Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 207144
Company: RICONPHARMA LLC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BETAMETHASONE VALERATE BETAMETHASONE VALERATE 0.12% AEROSOL, FOAM;TOPICAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/24/2017 ORIG-1 Approval STANDARD

Label is not available on this site.

BETAMETHASONE VALERATE

AEROSOL, FOAM;TOPICAL; 0.12%
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BETAMETHASONE VALERATE BETAMETHASONE VALERATE 0.12% AEROSOL, FOAM;TOPICAL Prescription No AB 078337 PERRIGO UK FINCO
BETAMETHASONE VALERATE BETAMETHASONE VALERATE 0.12% AEROSOL, FOAM;TOPICAL Prescription No AB 207144 RICONPHARMA LLC
BETAMETHASONE VALERATE BETAMETHASONE VALERATE 0.12% AEROSOL, FOAM;TOPICAL Prescription No AB 208204 TARO
LUXIQ BETAMETHASONE VALERATE 0.12% AEROSOL, FOAM;TOPICAL Prescription Yes AB 020934 MYLAN

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English